ChemicalBook >> CAS DataBase List >>ARD-2128

ARD-2128

CAS No.
2222111-87-5
Chemical Name:
ARD-2128
Synonyms
ARD-2128;orally,ARD2128,AR-regulated,bioavailable,inhibit,ARD 2128,Inhibitor,prostate,Androgen Receptor,cancer,ARD-2128,tumor,PROTACs;Benzamide, N-[trans-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]-4-[4-[[1-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-4-piperidinyl]methyl]-1-piperazinyl]-
CBNumber:
CB79731270
Molecular Formula:
C45H50ClN7O6
Molecular Weight:
820.37
MDL Number:
MFCD34567333
MOL File:
2222111-87-5.mol
Last updated:2024-07-02 08:55:17

ARD-2128 Properties

Boiling point 1000.4±65.0 °C(Predicted)
Density 1.39±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
form Solid
pka 10.83±0.40(Predicted)
color Light yellow to green yellow

ARD-2128 Chemical Properties,Uses,Production

Biological Activity

ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has the potential for the research of the prostate cancer[1]. ARD-2128 is highly potent and effective in the inhibition of cell growth in the VCaP cell line and LNCaP cell line with the IC50 values of 4 nM and 5 nM, respectively[1].ARD-2128 (1, 10, 100, and 1000 nM; 24 hours) effectively reduces the AR protein level by >50% at 1 nM and achieves the AR degradation of >90% at 10, 100, and 1000 nM, respectively, in VCaP cell[1]. ARD-2128 (20 mg/kg; p.o.; once) is effective in reducing the level of AR protein in mice after 24 hours[1].ARD-2128 (10-40 mg/kg; p.o.; daily for 21 days) shows antitumor activity in the VCaP xenograft model in mice[1].ARD-2128 (5mg/kg; p.o.) treatment shows the Cmax, AUC0-t and t1/2 values of 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively[1].

References

[1]. Han X, et al. Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer [published online ahead of print, 2021 Aug 25]. J Med Chem. 2021;10.1021/acs.jmedchem.1c00882.

ARD-2128 Preparation Products And Raw materials

Raw materials

Preparation Products

ARD-2128 Suppliers

Global( 13)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 52927 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 sales-cpd@caerulumpharma.com China 3431 58
DC Chemicals 021-58447131 13564518121 sales@dcchemicals.com China 9412 58
Chunchuang (Wuhan) Technology Co., Ltd 15342225168 yutianchun2007@126.com China 10009 58
Changzhou Borl Biotechnology Co.,LTD 13606124132;13656121842 luyan0021@163.com China 217 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24017 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581 sales@chemhifuture.com China 4371 58
Shanghai Easy CDMO Co.,Ltd 021-61734564 August@easycdmo.com China 10010 58
Suzhou Haiben Pharmaceutical Co., Ltd 14760821013 14760821013 1816280386@qq.com China 5208 58

ARD-2128 Spectrum

ARD-2128 orally,ARD2128,AR-regulated,bioavailable,inhibit,ARD 2128,Inhibitor,prostate,Androgen Receptor,cancer,ARD-2128,tumor,PROTACs Benzamide, N-[trans-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]-4-[4-[[1-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-4-piperidinyl]methyl]-1-piperazinyl]- 2222111-87-5